From January 1, 2024 to March 31, 2024, the company has repurchased 5,198,975 shares, representing 0.42% for $400 million. With this, the company has completed the repurchase of 18,663,819 shares, representing 1.5% for $1,475.28 million under the buyback announced on February 25, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.01 USD | -0.95% | +3.22% | -17.28% |
May. 14 | Transcript : Gilead Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM | |
May. 09 | Declaration of Voting Results by Gilead Sciences | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.28% | 84.28B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Tranche Update on Gilead Sciences, Inc.'s Equity Buyback Plan announced on February 25, 2020.